Find an MSK Doctor or Cancer Specialist
Jeffrey Zwicker

Jeffrey Zwicker, MD

Hematologist

My Role at MSK

Areas of Expertise

Conditions I Treat

  • Deep vein thrombosis (DVT)
  • Pulmonary embolism
  • Blood disorders and hemoglobinopathies

My Specialties

  • Hematology
  • Managing symptoms of cancer treatment
  • Anticoagulation
View all
Dr. Zwicker's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top
Share

About Me

What I Do at MSK
  • Chief, Hematology Service
Get To Know Me

As Chief of the Hematology Service at Memorial Sloan Kettering Cancer Center (MSK), I lead a team of hematologists that sees approximately 4,040 patients with benign blood disorders each year.

At MSK, my fellow hematologists and I collaborate to deliver personalized cancer care that considers each patient’s needs and preferences. When I meet with patients, I don’t just treat them as if they were my own family members — I try to put myself in their shoes.

Often, patients are concerned about the blood-related complications that can occur with cancer treatment. Some of the most common questions that patients ask me relate to the likelihood of experiencing blood-related complications on a medication, other possible side effects, and how long they need to be on a specific therapy. I take the time to clearly explain what patients can expect and address the concerns related to their condition. No matter the diagnosis, there is world-class expertise at MSK.

Read more

In patients with cancer, blood-related disorders, such as blood clots, low blood counts including anemia, and bleeding disorders, which may require special attention, regardless of whether the disorder is pre-existing, or a side effect of cancer treatment. Patients who already had a blood disorder before they were diagnosed with cancer might need tailored therapies.

Sometimes, patients receiving cancer therapy will experience blood-related side effects. These can include blood clots that form in a deep vein (deep vein thrombosis [DVT]) or decreases in the number of platelets in the blood (thrombocytopenia). Cancer-associated thrombosis is a condition that can develop when someone is undergoing treatment for cancer. Beyond caring for existing blood-related disorders, the Hematology Service also provides prompt medical attention to address any blood-related side effects, including thrombosis.

In addition to caring for patients with benign blood disorders, I study cancer-associated thrombosis to better understand its risk factors and develop novel treatment approaches. To date, I have led several National Institutes of Health-funded studies in cancer-associated thrombosis. I currently serve as the Chair of the International Society on Thrombosis and Haemostasis. Inc.’s (ISTH) subcommittee on hemostasis and thrombosis. I also previously acted as the Vice-Chair and Chair of the American Society of Hematology’s subcommittee on thrombosis and vascular biology. Through research and leadership in national and international professional organizations dedicated to thrombosis, I hope to improve the prevention and treatment of cancer-associated thrombosis.

 

My Role at MSK

A hematologist (HEE-muh-TAH-loh-jist) is a doctor with special training in blood disorders.

Areas of Expertise

Conditions I Treat

  • Deep vein thrombosis (DVT)
  • Pulmonary embolism
  • Blood disorders and hemoglobinopathies
  • Anemia and cancer
  • Blood clots and cancer
  • Thrombocytopenia and other bleeding disorders
  • Pulmonary conditions
  • Complications of cancer

My Specialties

  • Hematology
  • Managing symptoms of cancer treatment
  • Anticoagulation
Education & Honors

Education

  • MD, Penn State College of Medicine
  • MMS, Harvard Medical School

Residencies

  • Intern and Resident, Beth Israel Deaconess Medical Center, Harvard Medical School

Awards and Honors

  • Gordon J. Strewler Mentorship of Resident Research Award, Department of Medicine, Beth Israel Deaconess Medical Center (2021)
  • Program for Emerging Leaders, Harvard Medical School (2015)
  • Merck Award for Outstanding Academic Performance, Penn State College of Medicine (1998)

Fellowships

  • Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School

Board Certifications

  • Hematology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA and NYC retirees only)

In Network Coverage Type
PPO

Anthem BCBS and other BCBS licensee plans

In Network Coverage Type
PPO, POS, EPO, HMO

See updates

Anthem BCBS Health Plus

In Network Coverage Type
HMO

See updates

Anthem Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

See updates

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

See updates

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

See updates

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage (Medicare Choice PPO Network and VIP Prime Network Only)

In Network Coverage Type
PPO, HMO

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

See updates

Fidelis

In Network Coverage Type
HMO, EPO

Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

See updates

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

See updates

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 800-525-2225— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Zwicker sees patients at one location.

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Hematology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

View a list of Dr. Zwicker’s publications.

Wang TF, Sanfilippo KM, Douketis J, Falanga A, Karageorgiou J, Maraveyas A, Ortel TL, Soff G, Vedantham S, Zwicker JI. Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Sep 26. doi: 10.1111/jth.15896. Epub ahead of print. PMID: 36217296.

Khan AM, Chiasakul T, Redd R, Patell R, McCarthy EP, Neuberg D, Zwicker JI. Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study. PLoS Med. 2022 May 25;19(5):e1004012. doi: 10.1371/journal.pmed.1004012. PMID: 35613184; PMCID: PMC9182592.

Sharda AV, Bogue T, Barr A, Mendez LM, Flaumenhaft R, Zwicker JI. Circulating Protein Disulfide Isomerase Is Associated with Increased Risk of Thrombosis in JAK2-Mutated Myeloproliferative Neoplasms. Clin Cancer Res. 2021 Oct 15;27(20):5708-5717. doi: 10.1158/1078-0432.CCR-21-1140. Epub 2021 Aug 16. PMID: 34400417; PMCID: PMC9170286.

Read more

Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020 Sep 10;136(11):1342-1346. doi: 10.1182/blood.2020007938. PMID: 32766883; PMCID: PMC7483433.

Zwicker JI, Schlechter BL, Stopa JD, Liebman HA, Aggarwal A, Puligandla M, Caughey T, Bauer KA, Kuemmerle N, Wong E, Wun T, McLaughlin M, Hidalgo M, Neuberg D, Furie B, Flaumenhaft R; CATIQ Investigators11. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight. 2019 Feb 21;4(4):e125851. doi: 10.1172/jci.insight.125851. PMID: 30652973; PMCID: PMC6478409.

Publications on PubMed

Visit PubMed for a full listing of Dr. Zwicker’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Jeffrey Zwicker discloses the following relationships and financial interests:

  • BioClinica
    Professional Services and Activities
  • CSL Behring
    Professional Services and Activities
  • International Society on Thrombosis and Haemostasis
    Professional Services and Activities
  • Parexel International
    Professional Services and Activities
  • UptoDate
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: